We found PRMT5 expression was upregulated during HTLV-1-mediated T-cell transformation, as well as in established lymphocytic leukemia/lymphoma cell lines and ATLL patient PBMCs. The gene discussed is PRMT5; the disease is adult T-cell leukemia/lymphoma.